Testing effectiveness (Phase 2)Active Not RecruitingNCT03158064
What this trial is testing
Evaluating Immune Therapy, Duravalumab (MEDI4736) With Tremelimumab for Relapsed/Refractory Germ Cell Tumors
Who this might be right for
Germ Cell TumorNonseminomatous Germ Cell TumorSeminoma+3 more
Memorial Sloan Kettering Cancer Center 30